Posted on 04/20/2021 at 7:28 am, updated at 11:20 pm
The Basics In its highly anticipated report on Tuesday, the European Medicines Agency noted that the risk-benefit ratio remained “positive” for the Johnson & Johnson vaccine, which was suspended in France eight years ago . Despite this setback, the campaign continues. One in four French people has now received at least one dose. In this directory you will find all the news about the coronavirus in the region, in France and in the world from this Tuesday April 20th.
Will the Johnson & Johnson vaccine be used in France? This hints at the report submitted Tuesday by the European Medicines Agency (EMA) which estimated that the benefit-risk balance of the vaccine remained “positive” after examining the clot cases that have occurred in the US. However, the EMA believes that, as with the vaccine developed by AstraZeneca, blood clots should be added to the rare side effects.